• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家庭医生对血清前列腺特异性抗原(PSA)检测异常结果的认知

Perception of abnormal serum prostate-specific antigen (PSA) test results amongst family practitioners.

作者信息

Rochester M A, Donaldson P J, McLoughlin J

机构信息

Department of Urology, West Suffolk and Ipswich Hospitals, Suffolk, UK.

出版信息

Ann R Coll Surg Engl. 2008 Jul;90(5):398-402. doi: 10.1308/003588408X301019.

DOI:10.1308/003588408X301019
PMID:18634736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2645742/
Abstract

INTRODUCTION

With increased use of serum prostate-specific antigen (PSA) testing, prostate cancers are diagnosed at an earlier stage in younger men, when radical curative treatments are appropriate. Modifications of the PSA test such as PSA velocity and age-adjusted values are available to aid in the selection of patients for biopsy. However, it is not clear whether these data are used in general practice.

PATIENTS AND METHODS

A self-administered questionnaire was mailed to all primary care practices within one region in the UK. A series of visual analogue questions designed to identify referral thresholds for age-adjusted PSA levels and PSA velocity were used to identify patterns in referral behaviour.

RESULTS

Individual family practitioners see only small numbers of patients requesting PSA tests or with newly diagnosed prostate cancer each year. The median (range) thresholds considered for referral at ages 45, 55, 65, 75 and 85 years were 4.5 ng/ml (2.5-15.5 ng/ml), 5.5 ng/ml (3.0-15.5 ng/ml), 6.5 ng/ml (3.5-15.5 ng/ml), 6.5 ng/ml (3.5-25.5 ng/ml), and 7.5 ng/ml (3.5-25.5 ng/ml), respectively. Only 5% of practitioners correctly identified the age-specific PSA threshold for referral of a 45-year-old man.

CONCLUSIONS

It is important to remember that younger men (even those in their forties and fifties) may be at risk of prostate cancer even if asymptomatic. It is important in a climate of increasing demand for PSA testing that those who initiate the process understand the implications and limitations of testing, including appropriate triggers for referral to secondary care. The exact approach required for the successful dissemination of this information to primary care is not clear, but our data suggest that a better understanding is required.

摘要

引言

随着血清前列腺特异性抗原(PSA)检测的使用增加,前列腺癌在年轻男性中得以在更早阶段被诊断出来,此时根治性治疗是合适的。PSA检测的一些修正指标,如PSA速率和年龄校正值,可用于帮助选择活检患者。然而,尚不清楚这些数据在常规医疗实践中是否被使用。

患者与方法

向英国一个地区内的所有初级医疗诊所邮寄了一份自填式问卷。一系列旨在确定年龄校正PSA水平和PSA速率转诊阈值的视觉模拟问题,被用于识别转诊行为模式。

结果

个体家庭医生每年仅接待少量要求进行PSA检测或新诊断为前列腺癌的患者。45岁、55岁、65岁、75岁和85岁时考虑转诊的中位数(范围)阈值分别为4.5纳克/毫升(2.5 - 15.5纳克/毫升)、5.5纳克/毫升(3.0 - 15.5纳克/毫升)、6.5纳克/毫升(3.5 - 15.5纳克/毫升)、6.5纳克/毫升(3.5 - 25.5纳克/毫升)和7.5纳克/毫升(3.5 - 25.5纳克/毫升)。只有5%的医生正确识别了45岁男性转诊的年龄特异性PSA阈值。

结论

重要的是要记住,即使无症状,年轻男性(甚至四五十岁的男性)也可能有患前列腺癌的风险。在对PSA检测需求不断增加的情况下,启动检测过程的人了解检测的影响和局限性,包括转诊至二级医疗的适当触发因素非常重要。将这些信息成功传播到初级医疗所需的确切方法尚不清楚,但我们的数据表明需要更好地理解。

相似文献

1
Perception of abnormal serum prostate-specific antigen (PSA) test results amongst family practitioners.家庭医生对血清前列腺特异性抗原(PSA)检测异常结果的认知
Ann R Coll Surg Engl. 2008 Jul;90(5):398-402. doi: 10.1308/003588408X301019.
2
PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK.前列腺癌的前列腺特异性抗原检测:对英国全科医生观点及报告实践的在线调查
BMC Fam Pract. 2005 Jun 9;6(1):24. doi: 10.1186/1471-2296-6-24.
3
Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.全科医疗中的前列腺特异性抗原检测:丹麦325名全科医生的调查。
Scand J Urol Nephrol. 2005;39(3):214-8. doi: 10.1080/00365590510031084.
4
General practitioner perception of prostate-specific antigen testing has improved, but more awareness of prostate cancer risk in younger patients is still awaited.全科医生对前列腺特异性抗原检测的认知有所提高,但仍期待对年轻患者的前列腺癌风险有更多认识。
Prostate Int. 2018 Jun;6(2):61-65. doi: 10.1016/j.prnil.2017.10.001. Epub 2017 Oct 14.
5
Abnormal PSA tests--delays in referral.异常的前列腺特异性抗原(PSA)检测——转诊延迟。
Aust Fam Physician. 2008 Jan-Feb;37(1-2):84-8.
6
Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer.制定针对不同年龄阶段的前列腺癌检测前列腺特异性抗原阈值。
Cancer Causes Control. 2018 Mar;29(3):383-388. doi: 10.1007/s10552-018-1014-3. Epub 2018 Feb 16.
7
Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners.在一个没有相关指南的国家,促使无症状男性进行前列腺特异性抗原(PSA)检测的因素:一项针对全科医生的全国性调查
BMC Fam Pract. 2009 Jan 12;10:3. doi: 10.1186/1471-2296-10-3.
8
Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.安大略省的前列腺特异性抗原检测:对未确诊前列腺癌患者进行检测的原因
CMAJ. 1999 Jan 12;160(1):70-5.
9
Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff.德国前列腺癌的早期检测:一项使用直肠指检和以4.0 ng/ml前列腺特异性抗原为临界值的研究。
Eur Urol. 2001 Feb;39(2):131-7. doi: 10.1159/000052427.
10
Biopsy follow-up of prostate-specific antigen tests.前列腺特异性抗原检测的活检随访。
Am J Prev Med. 2012 Jan;42(1):37-43. doi: 10.1016/j.amepre.2011.08.024.

引用本文的文献

1
General practitioner perception of prostate-specific antigen testing has improved, but more awareness of prostate cancer risk in younger patients is still awaited.全科医生对前列腺特异性抗原检测的认知有所提高,但仍期待对年轻患者的前列腺癌风险有更多认识。
Prostate Int. 2018 Jun;6(2):61-65. doi: 10.1016/j.prnil.2017.10.001. Epub 2017 Oct 14.
2
[Rates of prostate-specific antigen testing for early detection of prostate cancer: a first comparison of German results with current international data].[用于前列腺癌早期检测的前列腺特异性抗原检测率:德国结果与当前国际数据的首次比较]
Urologe A. 2014 May;53(5):715-24. doi: 10.1007/s00120-014-3453-0.
3
Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review.全球范围内前列腺特异性抗原检测政策差异很大,似乎不符合指南:系统评价。
BMC Fam Pract. 2012 Oct 11;13:100. doi: 10.1186/1471-2296-13-100.

本文引用的文献

1
PSA testing: are patients aware of what lies ahead?前列腺特异性抗原检测:患者知晓未来会怎样吗?
Ann R Coll Surg Engl. 2006 May;88(3):284-8. doi: 10.1308/003588406X98685.
2
The increased rate of prostate specific antigen testing has not affected prostate cancer presentation in an inner city population in the UK.前列腺特异性抗原检测率的提高并未影响英国一个市中心城区人群中前列腺癌的表现。
BJU Int. 2006 Feb;97(2):266-9. doi: 10.1111/j.1464-410X.2005.06011.x.
3
Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam.欧洲前列腺癌筛查随机研究(鹿特丹部分)中经筛查发现与临床诊断的前列腺癌的比较
J Urol. 2005 Jul;174(1):121-5. doi: 10.1097/01.ju.0000162061.40533.0f.
4
PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK.前列腺癌的前列腺特异性抗原检测:对英国全科医生观点及报告实践的在线调查
BMC Fam Pract. 2005 Jun 9;6(1):24. doi: 10.1186/1471-2296-6-24.
5
Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study.英格兰和威尔士普通医疗中无症状和有症状患者的前列腺特异性抗原检测率:一项横断面研究。
BJU Int. 2004 Jul;94(1):51-6. doi: 10.1111/j.1464-4096.2004.04832.x.
6
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.前列腺特异性抗原水平≤4.0纳克/毫升的男性中前列腺癌的患病率。
N Engl J Med. 2004 May 27;350(22):2239-46. doi: 10.1056/NEJMoa031918.
7
Evidence of prostate cancer screening in a UK region.英国某地区前列腺癌筛查的证据。
BJU Int. 2004 Apr;93(6):730-4. doi: 10.1111/j.1464-410X.2003.04716.x.
8
Promoting better use of the PSA test in general practice: randomized controlled trial of educational strategies based on outreach visits and mailout.在全科医疗中促进前列腺特异性抗原(PSA)检测的更好应用:基于外展访问和邮寄的教育策略随机对照试验
Fam Pract. 2003 Dec;20(6):655-61. doi: 10.1093/fampra/cmg606.
9
Survey of the rate of PSA testing in general practice.全科医疗中PSA检测率的调查。
Br J Cancer. 2001 Sep 1;85(5):656-7. doi: 10.1054/bjoc.2001.1962.
10
Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994.前列腺癌发病率的时间趋势:1974年至1994年晚期疾病发病率下降
J Urol. 1997 Oct;158(4):1427-30. doi: 10.1016/s0022-5347(01)64231-9.